Please use this identifier to cite or link to this item:
Title: Exhaled breath condensate to discriminate individuals with different smoking habits by GC-TOF/MS.
Authors: Peralbo-Molina, A
Calderón-Santiago, M
Jurado-Gámez, B
Luque de Castro, M D
Priego-Capote, F
metadata.dc.subject.mesh: Biomarkers
Breath Tests
Cohort Studies
Middle Aged
ROC Curve
Tobacco Smoking
Issue Date: 3-May-2017
Abstract: Smoking is a crucial factor in respiratory diseases and lung inflammation, which are the reasons for high mortality worldwide. Despite the negative impact that tobacco consumption causes on health, few metabolomics studies have compared the composition of biofluids from smoker and non-smoker individuals. Exhaled breath condensate (EBC) is one of the biofluids less employed for clinical studies despite its non-invasive sampling and the foreseeable relationship between its composition and respiratory diseases. EBC was used in this research as clinical sample to compare three groups of individuals: current smokers (CS), former smokers (FS) and never smokers (NS). Special attention was paid to the cumulative consumption expressed as smoked pack-year. The levels of 12 metabolites found statistically significant among the three groups of individuals were discussed to find an explanation to their altered levels. Significant compounds included monoacylglycerol derivatives, terpenes and other compounds, the presence of which could be associated to the influence of smoking on the qualitative and quantitative composition of the microbiome.
metadata.dc.identifier.doi: 10.1038/s41598-017-01564-z
Appears in Collections:Producción 2020

Files in This Item:
File SizeFormat 
PMC5431160.pdf1,88 MBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons